TRIALS OF COURAGE
“This clinical trial will either be the most important clinical trial that happend in all of oncology in the next five years…
…or it will be the biggest dud”
The problem:
People are dying of Melanoma cancer
Dr. Jason Luke of UPMC Hillman Cancer Center
The idea behind it
Dr. Stephen Hoge President of Moderna
The opportunity:
A life saving cancer vaccine
Dr. Meredith McKean of the Sarah Cannon Research Institute
Unchartered territory
Dr. Michelle Brown, Program Leader, Oncology at Moderna
The world’s first personalized vaccine for Melanoma.
A Watershed moment for treating cancer
Moderna Team
Scientist that founded Moderna
Scientists
President of Moderna.
Head Investor Relations at Moderna
One half of the Nobel Prize winning scientist team that pioneered mRNA research.
CEO of Moderna.
The other half of the Nobel Prize winning scientist team that made mRNA a viable option in the world of immunology.
Entrepreneur and venture capitalist that co-founded Moderna.
Vaccine Trial Doctors
Ryan Sullivan
FEATURING
Meredith McKean
Thuy Tran
Jason Luke
Going to market
Should the phase III clinical trial results of the melanoma cancer vaccine prove to be as positive as the phase II were, it will be fast tracked to market and be the first ever personalized cancer vaccine approved by the FDA.
For more than 100 years, Harvard Business Review has defined the global business agenda, publishing the most influential ideas around capitalism, leadership, innovation, and strategy. Landmark books like The Innovator's Dilemma, Blue Ocean Strategy, Conscious Capitalism, and many, many more provide the strategies and ideas that drive businesses every day. Defining ideas born in the pages of HBR and its books proliferate through the media company's many platforms, from books to magazines, online, events, and now to films, through the newly launched HBR Productions. HBR's unique capabilities—its unparalleled access to global leaders and business thinkers, its rich archive of case studies and decades of trendsetting content—bring to life the crucial business stories that affect all of us, everywhere.